SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
4049looks like about 400M, give or take...... OSI Pharmaceuticals Announces Filing scaram(o)uche9/23/2004
4048Ligand Earns Milestone as Pfizer Submits NDA for Lasofoxifene for Osteoporosis Tscaram(o)uche9/16/2004
4047Roche in cooperation talks with several Danish biotech cos COPENHAGEN (AFX) - Rnigel bates9/16/2004
4046Active Biotech proposes a rights issue of convertible debentures totalling SEK 1nigel bates9/15/2004
4045Cellegy Receives Marketing Approval for Cellegesic(TM) in United Kingdom Monday scaram(o)uche9/13/2004
4044Nesiritide Treatment Associated with Significantly Reduced In-Hospital Mortalityscaram(o)uche9/13/2004
4043Texas Biotech...... Encysive Pharmaceuticals Announces Closing of $36.5 Millionscaram(o)uche9/13/2004
40429/11 whores are willing to sell, coming into this weekend. Some of them will evscaram(o)uche9/9/2004
4041Tourists to Another Stock Bubble? <i>Not biotech-specific - Doc</i>Doc Bones9/8/2004
4040continuing, from this week's BC...... <i>The piggybank is fuller todascaram(o)uche9/6/2004
4039from this week's BioCentury (thanks, R!)..... Over the period from Dec. 31,scaram(o)uche9/6/2004
4038Enanta Pharmaceuticals Raises $20 Million in New Financing and Initiates Phase 1nigel bates8/31/2004
4037hop and skip.... Message 20465323scaram(o)uche8/30/2004
4036Message 20450277scaram(o)uche8/25/2004
4035Metaphore Pharmaceuticals, Inc. Raises $40.2 Million in Series D Financing Tuesdscaram(o)uche8/24/2004
4034Bayer, Apax Form Venture Focusing on Respiratory Drugs A WALL STREET JOURNAL ONDoc Bones8/24/2004
4033NitroMed Fans, From the Very Start Outside Audit Strong Heart-Drug Reviews EmanDoc Bones8/23/2004
4032It's scary to me that even though I had posted that news item last week, I tsjemmeri8/20/2004
4031Peter, Yes: Message 20407848 Cheers, Tucktuck8/20/2004
4030<i>xenomouse-derived MAb</i> Is this an ABGX derived MAb? If so, woBiomaven8/20/2004
4029*Single* sub q dose of 162 performed equal or better than weekly fosamax at all rkrw8/20/2004
4028haven't a clue. this is one of my most pronounced areas of ignorance. likescaram(o)uche8/19/2004
4027Rick, what is your take on this agent?...compared to what's out there now(Aczeta19618/19/2004
4026while I was on vacation.... to my knowledge, only the second xenomouse-derivescaram(o)uche8/19/2004
4025Array BioPharma and QLT Announce Drug Discovery Collaboration Focused on Cancer mopgcw8/10/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News